Enzyme Bioscience Profile
Key Indicators
- Authorised Capital ₹ 4.80 M
as on 16-11-2024
- Paid Up Capital ₹ 4.80 M
as on 16-11-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.25 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.55 Cr
as on 16-11-2024
- Revenue 1.84%
(FY 2023)
- Profit 27.68%
(FY 2023)
- Ebitda -96.67%
(FY 2023)
- Net Worth 16.44%
(FY 2023)
- Total Assets -20.47%
(FY 2023)
About Enzyme Bioscience
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.80 M and a paid-up capital of Rs 4.80 M.
The company currently has active open charges totaling ₹14.25 Cr. The company has closed loans amounting to ₹1.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nanubhai Gangadia, Mukeshbhai Rasadiya, and Bharatbhai Gangadiya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC075993
- Company No.
075993
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Enzyme Bioscience Private Limited offer?
Enzyme Bioscience Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Nutraceuticals & Dietary Supplements, Weight Gain Nutrition, Bakery & Confectionery Products, Confectionery Ingredients, Bird Food, Poultry & Animal Food, Fish Foods, Nutraceuticals, Flavours & Aromatics.
Who are the key members and board of directors at Enzyme Bioscience?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nanubhai Gangadia | Director | 11-Jul-2013 | Current |
Mukeshbhai Rasadiya | Director | 11-Jul-2013 | Current |
Bharatbhai Gangadiya | Director | 11-Jul-2013 | Current |
Financial Performance of Enzyme Bioscience.
Enzyme Bioscience Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.84% increase. The company also saw a substantial improvement in profitability, with a 27.68% increase in profit. The company's net worth Soared by an impressive increase of 16.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Enzyme Bioscience?
In 2023, Enzyme Bioscience had a public holding of 27.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Wishrut Pharma Private LimitedActive 3 years 10 months
Nanubhai Gangadia, Mukeshbhai Rasadiya and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Sidbi Creation Date: 03 Aug 2023 | ₹4.33 Cr | Open |
Others Creation Date: 28 Jun 2023 | ₹1.03 Cr | Open |
Others Creation Date: 28 Jun 2023 | ₹3.40 Cr | Open |
How Many Employees Work at Enzyme Bioscience?
Unlock and access historical data on people associated with Enzyme Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enzyme Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzyme Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.